Country: United States
Language: English
Source: NLM (National Library of Medicine)
ZOLMITRIPTAN (UNII: 2FS66TH3YW) (ZOLMITRIPTAN - UNII:2FS66TH3YW)
Zydus Lifesciences Limited
ZOLMITRIPTAN
ZOLMITRIPTAN 2.5 mg
ORAL
PRESCRIPTION DRUG
Zolmitriptan orally disintegrating tablets are indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use - Only use zolmitriptan if a clear diagnosis of migraine has been established. If a patient has no response to zolmitriptan treatment for the first migraine attack, reconsider the diagnosis of migraine before zolmitriptan is administered to treat any subsequent attacks. - Zolmitriptan orally disintegrating tablets are not indicated for the prevention of migraine attacks. - Safety and effectiveness of zolmitriptan have not been established for cluster headache. Zolmitriptan orally disintegrating tablets are contraindicated in patients with: - Ischemic coronary artery disease (angina pectoris, history of myocardial infarction, or documented silent ischemia), other significant underlying cardiovascular disease, or c oronary artery vasospasm including Prinzmetal's angina [seeWarnings and Precautions (5.1) ]. - Wolff-Parkinson-White syndrome or arrhythmias associa
Zolmitriptan Orally Disintegrating Tablets, 2.5 mg are white/mottled white to cream white, round, flat-faced, uncoated tablet, debossed with '715' on one side and plain on the other side and are supplied as follows: NDC 65841-767-06 in bottle of 30 tablets NDC 65841-767-16 in bottle of 90 tablets NDC 65841-767-01 in bottle of 100 tablets NDC 65841-767-10 in bottle of 1000 tablets NDC 65841-767-86 in unit-dose blister cartons of 6 (1 x 6) unit dose tablets NDC 65841-767-77 in unit-dose blister cartons of 100 (10 x 10) unit dose tablets Zolmitriptan Orally Disintegrating Tablets, 5 mg are white/mottled white to cream white, round, biconvex, beveled, uncoated tablet, debossed with '717' on one side and plain on the other side and are supplied as follows: NDC 65841-768-06 in bottle of 30 tablets NDC 65841-768-16 in bottle of 90 tablets NDC 65841-768-01 in bottle of 100 tablets NDC 65841-768-10 in bottle of 1000 tablets NDC 65841-768-82 in unit-dose blister cartons of 3 (1 x 3) unit dose tablets NDC 65841-768-77 in unit-dose blister cartons of 100 (10 x 10) unit dose tablets Storage and Handling Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Protect from light and moisture. Dispense in a tight, light-resistant closed container.
Abbreviated New Drug Application
ZOLMITRIPTAN - ZOLMITRIPTAN TABLET, ORALLY DISINTEGRATING ZYDUS LIFESCIENCES LIMITED ---------- ZOLMITRIPTAN ORALLY DISTRAGING TABLETS NDC 65841-767-10 in bottle of 1000 Tablets Zolmitriptan Orally Disintegrating Tablets, 2.5 mg Rx only 1000 Tablets NDC 65841-768-10 in bottle of 1000 Tablets Zolmitriptan Orally Disintegrating Tablets, 5 mg Rx only 1000 Tablets ZOLMITRIPTAN zolmitriptan tablet, orally disintegrating PRODUCT INFORMATION PRODUCT TYPE HUMAN PRESCRIPTION DRUG ITEM CODE (SOURCE) NDC:65841-767 ROUTE OF ADMINISTRATION ORAL ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRENGTH ZOLMITRIPTAN (UNII: 2FS66TH3YW) (ZOLMITRIPTAN - UNII:2FS66TH3YW) Z OLMITRIPTAN 2.5 mg INACTIVE INGREDIENTS INGREDIENT NAME STRENGTH ANHYDROUS CITRIC ACID (UNII: XF417D3PSL) ASPARTAME (UNII: Z0H242BBR1) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) CROSPOVIDONE (15 MPA.S AT 5%) (UNII: 68401960MK) GELATIN (UNII: 2G86QN327L) MAGNESIUM STEARATE (UNII: 70097M6I30) MANNITOL (UNII: 3OWL53L36A) CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) ORANGE (UNII: 5EVU04N5QU) POLACRILIN POTASSIUM (UNII: 0BZ5A00FQU) SODIUM STEARYL FUMARATE (UNII: 7CV7WJK4UI) PRODUCT CHARACTERISTICS COLOR WHITE (WHITE/MOTTLED WHITE TO CREAM WHITE) SCORE no score SHAPE ROUND (ROUND) SIZE 6mm FLAVOR ORANGE (ORANGE) IMPRINT CODE 715 CONTAINS PACKAGING # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:65841- 767-06 30 in 1 BOTTLE; Type 0: Not a Combination Product 05/16/2013 2 NDC:65841- 767-16 90 in 1 BOTTLE; Type 0: Not a Combination Product 05/16/2013 3 NDC:65841- 767-01 100 in 1 BOTTLE; Type 0: Not a Combination Product 05/16/2013 4 NDC:65841- 767-10 1000 in 1 BOTTLE; Type 0: Not a Combination Product 05/16/2013 5 NDC:65841- 767-86 1 in 1 CARTON 05/16/2013 5 NDC:65841- 767-69 6 in 1 BLISTER PACK; Type 0: Not a Combination Product 6 NDC:65841- 767-77 10 in 1 CARTON 05/16/2013 6 NDC:65841- 767-30 10 in 1 BLISTER PACK; Type 0: Not a Combination Product MARKETING INFORMATION MARKETING CATEGORY APPLICATION NUMBER OR MONOGRAPH CITATION M Read the complete document